Bone Biologics (BBLGW) Receivables - Other (2014 - 2015)
Bone Biologics' (BBLGW) quarterly Receivables - Other came in at $75000.0 in Q3 2015, down 50.0% quarter-over-quarter from $150000.0 in Q2 2015.
Powered by 
Analysis
Bone Biologics (BBLGW) Receivables - Other (2014 - 2015) Analysis & Trends
Bone Biologics (BBLGW) has reported Receivables - Other for 2 consecutive years, with $75000.0 the latest figure, recorded in Q3 2015.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $75000.0 in Q3 2015; TTM through Sep 2015 was $75000.0, a N/A change from a year earlier, with the FY2015 full-year figure at -$75000.0, down 200.0% from the prior year.
- Receivables - Other was $75000.0 for Q3 2015 at Bone Biologics, down from $150000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $150000.0 in Q2 2015 and troughed at $75000.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn |
| 10 | Bone Biologics | 9.52 Mn | 9.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 75,000.00 |
| Jun 30, 2015 | 150,000.00 |
| Dec 31, 2014 | 75,000.00 |